DZ3040A1 - Benzolactames et thioamides cycliques substitués nouveaux, procédé pour préparation et compositions pharmaceutiques les contenant. - Google Patents
Benzolactames et thioamides cycliques substitués nouveaux, procédé pour préparation et compositions pharmaceutiques les contenant.Info
- Publication number
- DZ3040A1 DZ3040A1 DZ000082A DZ000082A DZ3040A1 DZ 3040 A1 DZ3040 A1 DZ 3040A1 DZ 000082 A DZ000082 A DZ 000082A DZ 000082 A DZ000082 A DZ 000082A DZ 3040 A1 DZ3040 A1 DZ 3040A1
- Authority
- DZ
- Algeria
- Prior art keywords
- benzolactams
- preparation
- pharmaceutical compositions
- compositions containing
- substituted cyclic
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/20—Oxygen atoms
- C07D215/22—Oxygen atoms attached in position 2 or 4
- C07D215/227—Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
- A61K31/382—Heterocyclic compounds having sulfur as a ring hetero atom having six-membered rings, e.g. thioxanthenes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
- C07D209/32—Oxygen atoms
- C07D209/34—Oxygen atoms in position 2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
- C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Immunology (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Diabetes (AREA)
- Dermatology (AREA)
- Urology & Nephrology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Hematology (AREA)
- Pulmonology (AREA)
- Rheumatology (AREA)
- Transplantation (AREA)
- Endocrinology (AREA)
- Oncology (AREA)
- Addiction (AREA)
- Psychology (AREA)
- Communicable Diseases (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Obesity (AREA)
- Hospice & Palliative Care (AREA)
- Reproductive Health (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US13285899P | 1999-05-06 | 1999-05-06 |
Publications (1)
Publication Number | Publication Date |
---|---|
DZ3040A1 true DZ3040A1 (fr) | 2004-03-27 |
Family
ID=22455915
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DZ000082A DZ3040A1 (fr) | 1999-05-06 | 2000-05-03 | Benzolactames et thioamides cycliques substitués nouveaux, procédé pour préparation et compositions pharmaceutiques les contenant. |
Country Status (40)
Country | Link |
---|---|
EP (1) | EP1175417B1 (fr) |
JP (1) | JP2002544128A (fr) |
KR (1) | KR20020015319A (fr) |
CN (1) | CN1349527A (fr) |
AP (1) | AP2001002314A0 (fr) |
AR (1) | AR036320A1 (fr) |
AT (1) | ATE257478T1 (fr) |
AU (1) | AU3572800A (fr) |
BG (1) | BG106141A (fr) |
BR (1) | BR0010673A (fr) |
CA (1) | CA2373079A1 (fr) |
CR (1) | CR6505A (fr) |
CZ (1) | CZ20013977A3 (fr) |
DE (1) | DE60007625T2 (fr) |
DK (1) | DK1175417T3 (fr) |
DZ (1) | DZ3040A1 (fr) |
EA (1) | EA200101050A1 (fr) |
EE (1) | EE200100586A (fr) |
ES (1) | ES2211520T3 (fr) |
GE (1) | GEP20043224B (fr) |
GT (1) | GT200000063A (fr) |
HK (1) | HK1046144A1 (fr) |
HR (1) | HRP20010821A2 (fr) |
HU (1) | HUP0201135A3 (fr) |
IL (1) | IL145945A0 (fr) |
IS (1) | IS6122A (fr) |
MA (1) | MA26731A1 (fr) |
MY (1) | MY133207A (fr) |
NO (1) | NO20015395L (fr) |
NZ (1) | NZ514697A (fr) |
OA (1) | OA11864A (fr) |
PA (1) | PA8494901A1 (fr) |
PE (1) | PE20010119A1 (fr) |
PL (1) | PL351919A1 (fr) |
PT (1) | PT1175417E (fr) |
TN (1) | TNSN00095A1 (fr) |
TR (1) | TR200103222T2 (fr) |
UY (1) | UY26135A1 (fr) |
WO (1) | WO2000068224A1 (fr) |
ZA (1) | ZA200109116B (fr) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB0108982D0 (en) | 2001-04-10 | 2001-05-30 | Merck Sharp & Dohme | Therapeutic agents |
EP1460061A4 (fr) * | 2001-12-27 | 2006-05-31 | Toray Finechemicals Co Ltd | Processus de production de derive heterocyclique sature azote 1-alcoxycarbonyle |
JP2006523209A (ja) | 2003-03-12 | 2006-10-12 | アリゾナ ボード オブ リージェンツ オン ビハーフ オブ ザ ユニバーシティー オブ アリゾナ | アペリン組成物によって血管新生を調節するための方法 |
US7790745B2 (en) | 2005-10-21 | 2010-09-07 | Bristol-Myers Squibb Company | Tetrahydroisoquinoline LXR Modulators |
WO2009109001A1 (fr) * | 2008-03-04 | 2009-09-11 | Adelaide Research & Innovation Pty Ltd | Procédé de prévention et/ou de traitement d’une maladie, d’une condition ou d’un état associés à une fonction réduite des neurones dopaminergiques |
JP6156074B2 (ja) * | 2013-11-08 | 2017-07-05 | 住友化学株式会社 | スクシンイミド化合物及びその用途 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PT675886E (pt) * | 1992-12-10 | 2000-12-29 | Pfizer | Heterociclos nao aromaticos com substituintes aminometileno e sua utilizacao como antagonistas da substancia p |
DE69612003T2 (de) * | 1995-07-07 | 2001-06-21 | Pfizer Inc., New York | Substituierte benzolaktamverbindungen als substanz-p-antagonisten |
TW340842B (en) * | 1995-08-24 | 1998-09-21 | Pfizer | Substituted benzylaminopiperidine compounds |
DE69623580T2 (de) * | 1995-12-21 | 2003-01-09 | Pfizer Inc., New York | 3-((5-Substituierte Benzyl)Amino)-2-Phenylpiperidine als Substance-P-Antagonisten |
TW426667B (en) * | 1997-11-19 | 2001-03-21 | Pfizer | Piperidinylaminomethyl trifluoromethyl cyclic ether compounds as substance P antagonists |
-
2000
- 2000-04-13 GE GEAP20006190A patent/GEP20043224B/en unknown
- 2000-04-13 HU HU0201135A patent/HUP0201135A3/hu unknown
- 2000-04-13 DK DK00914335T patent/DK1175417T3/da active
- 2000-04-13 OA OA1200100264A patent/OA11864A/en unknown
- 2000-04-13 JP JP2000616198A patent/JP2002544128A/ja active Pending
- 2000-04-13 NZ NZ514697A patent/NZ514697A/en unknown
- 2000-04-13 EP EP00914335A patent/EP1175417B1/fr not_active Expired - Lifetime
- 2000-04-13 ES ES00914335T patent/ES2211520T3/es not_active Expired - Lifetime
- 2000-04-13 KR KR1020017014110A patent/KR20020015319A/ko not_active Application Discontinuation
- 2000-04-13 CZ CZ20013977A patent/CZ20013977A3/cs unknown
- 2000-04-13 CA CA002373079A patent/CA2373079A1/fr not_active Abandoned
- 2000-04-13 DE DE2000607625 patent/DE60007625T2/de not_active Expired - Fee Related
- 2000-04-13 AP APAP/P/2001/002314A patent/AP2001002314A0/en unknown
- 2000-04-13 IL IL14594500A patent/IL145945A0/xx unknown
- 2000-04-13 CN CN00807267A patent/CN1349527A/zh active Pending
- 2000-04-13 PT PT00914335T patent/PT1175417E/pt unknown
- 2000-04-13 TR TR2001/03222T patent/TR200103222T2/xx unknown
- 2000-04-13 WO PCT/IB2000/000461 patent/WO2000068224A1/fr not_active Application Discontinuation
- 2000-04-13 EA EA200101050A patent/EA200101050A1/ru unknown
- 2000-04-13 BR BR0010673-9A patent/BR0010673A/pt not_active IP Right Cessation
- 2000-04-13 PL PL00351919A patent/PL351919A1/xx not_active Application Discontinuation
- 2000-04-13 AU AU35728/00A patent/AU3572800A/en not_active Abandoned
- 2000-04-13 EE EEP200100586A patent/EE200100586A/xx unknown
- 2000-04-13 AT AT00914335T patent/ATE257478T1/de not_active IP Right Cessation
- 2000-05-03 PA PA20008494901A patent/PA8494901A1/es unknown
- 2000-05-03 MA MA25966A patent/MA26731A1/fr unknown
- 2000-05-03 TN TNTNSN00095A patent/TNSN00095A1/fr unknown
- 2000-05-03 DZ DZ000082A patent/DZ3040A1/fr active
- 2000-05-03 UY UY26135A patent/UY26135A1/es not_active Application Discontinuation
- 2000-05-04 MY MYPI20001922A patent/MY133207A/en unknown
- 2000-05-04 AR ARP000102150A patent/AR036320A1/es unknown
- 2000-05-05 GT GT200000063A patent/GT200000063A/es unknown
- 2000-05-05 PE PE2000000418A patent/PE20010119A1/es not_active Application Discontinuation
-
2001
- 2001-10-23 IS IS6122A patent/IS6122A/is unknown
- 2001-11-05 ZA ZA200109116A patent/ZA200109116B/en unknown
- 2001-11-05 NO NO20015395A patent/NO20015395L/no not_active Application Discontinuation
- 2001-11-06 HR HR20010821A patent/HRP20010821A2/hr not_active Application Discontinuation
- 2001-11-19 CR CR6505A patent/CR6505A/es not_active Application Discontinuation
- 2001-11-23 BG BG106141A patent/BG106141A/bg unknown
-
2002
- 2002-10-29 HK HK02107807.6A patent/HK1046144A1/zh unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DZ2963A1 (fr) | Dérivés de bicycliques substituées nouveaux, procédé pour leur préparation et compositions pharmaceutiques les contenant. | |
MA26659A1 (fr) | Dérivés de benzimidazole nouveaux, compositions pharmaceutiques les contenant et procédé pour leur préparation. | |
DZ3020A1 (fr) | Acides oxamiques nouveaux, procédé pour leur préparation et compositions pharmaceutiques les contenant. | |
DZ3000A1 (fr) | Macrolides nouveaux, procédé pour leur préparationet compositions pharmaceutiques les contenant. | |
DZ3045A1 (fr) | Dérivés de i 3-méthyl-érythromycine nouveaux, procédé pour leur préparation et compositions pharmaceutiques les contenant. | |
MA26622A1 (fr) | Pyrazolopyrimidinones nouvelles, procede pour leur preparation et compositions pharmaceutiques les contenant | |
DZ3042A1 (fr) | Dérivés d'isothiazole nouveaux, procédé pour leur préparation et compositions pharmaceutiques les contenant. | |
DZ2891A1 (fr) | Dérivés de tétrahydroquinoléines substués nouveaux, procédé pour leur préparation et compositions pharmaceutiques les contenant. | |
FR2827604B1 (fr) | Nouveaux derives de 1-phenylsulfonyl-1,3-dihydro-2h-indol-2- one, un procede pour leur preparation et les compositions pharmaceutiques en contenant | |
DZ3009A1 (fr) | Dérivés de quinoléine-2-one à substituant hétéroaryle nouveaux, procédé pour leur préparation et compositions pharmaceutiques les contenant. | |
MA26730A1 (fr) | Composes nouveaux antagonistes de npy, procede pour leur preparation et compositions pharmaceutiques les contenant | |
DZ3038A1 (fr) | Modulateurs nouveaux des récepteurs de glucocorticoïdes, procédé pour leur préparation et compositions pharmaceutiques les contenant. | |
FR2794742B1 (fr) | Nouveaux derives du benzene, un procede pour leur preparation et les compositions pharmaceutiques les contenant | |
FR2780057B1 (fr) | Phenoxypropanolamines, procede pour leur preparation et compositions pharmaceutiques les contenant | |
MA26630A1 (fr) | 4-phenylpyperidines nouvelles, procede pour leur preparation et compositions pharmaceutiques les contenant | |
FR2816938B1 (fr) | Derives de 3-aroylindole, leur procede de preparation et les compositions pharmaceutiques en contenant | |
DZ2866A1 (fr) | 1-Aryl-3-arylméthyl-1,8-naphtyridine-4-(1H)-ones nouvelles, procédé pour leur préparation et compositions pharmaceutiques les contenant. | |
CH689805A8 (fr) | Méthanesulfonate de paroxétine, procédé pour sa préparation et compositions pharmaceutiques le contenant. | |
MA26624A1 (fr) | Derives de quinazolinamines nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant | |
DZ2944A1 (fr) | Azalides nouveaux, procédé our leur préparation etcompositions pharmaceutiques les contenant. | |
MA26501A1 (fr) | Derives de quinoleine nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant | |
MA26642A1 (fr) | Derives de sulfonylbenzene nouveaux, procédé pour leur preparation et compositions pharmaceutiques les contenant. | |
DZ3023A1 (fr) | Dérivés de résorcinol, compositions pharmaceutiques les contenant et procédé pour leur préparation. | |
DZ3017A1 (fr) | Dérivés de 2-aminopyridine nouveaux, procédé pour Dérivés de 2-aminopyridine nouveaux, procédé pour leur préparation et compositions pharmaceutiques lleur préparation et compositions pharmaceutiques les contenant. es contenant. | |
FR2830531B1 (fr) | Acides naphtylsulfoniques nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant |